Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Lucia Lassiani"'
Publikováno v:
Pharmaceuticals
Research on the adenosine receptors has been supported by the continuous discovery of new chemical probes characterized by more and more affinity and selectivity for the single adenosine receptor subtypes (A1, A2A, A2B and A3 adenosine receptors). Fu
Autor:
Matteo Lusi, Miranda L. Perry, Michael J. Zaworotko, Dario Voinovich, Samuel Golob, Michele R. Chierotti, Lucia Lassiani, Iztok Grabnar
Publikováno v:
Journal of Pharmaceutical Sciences. 105:3626-3633
Vinpocetine is a poorly water soluble weakly basic drug (pKa = 7.1) used for the treatment of several cerebrovascular and cognitive disorders. Because existing formulations exhibit poor bioavailability and scarce absorption, a dosage form with improv
Autor:
Giuseppe Procida, Sara Drioli, Marina Zacchigna, Francesca Cateni, Patrizia Nitti, Marco Pelin, Lucia Lassiani, Chiara Florio
The α-methylene-γ-butyrolactone skeleton is part of many natural products with remarkable biological properties. C75, a fatty acid synthase (FAS) inhibitor, is a synthetic α-methylene-γ-butyrolactone which is cytotoxic for different cell lines in
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::11ec1e11735eb7483452e6cb2006e404
http://hdl.handle.net/11368/2933536
http://hdl.handle.net/11368/2933536
Autor:
Antonio Varnavas, Federico Berti, Theodoros Markidis, Francesco Makovec, Laura Mennuni, George Kokotos, Lucia Lassiani, Michela V. Pavan
Publikováno v:
Bioorganic & Medicinal Chemistry. 17:2336-2350
The anthranilic acid diamides represent the more recent class of nonpeptide CCK(1) receptor antagonists. This class is characterized by the presence of anthranilic acid, used as a molecular scaffold, and two pharmacophores selected from the C-termina
Publikováno v:
Il Farmaco. 55:293-302
A series of C-terminal anthranoyl-anthranilic acid derivatives arising from a strict bond disconnection approach of asperlicin were synthesized and examined for their CCK receptor affinities. These compounds represent the second step of our investiga
Autor:
Federico Berti, Laura Mennuni, Lucia Lassiani, Flora Ferrari, Alessia Ciogli, Francesco Makovec, Daniel Fourmy, Antonio Varnavas, Chantal Escrieut, Giorgio Stefancich, Francesco Gasparrini, Esther Marco, Michela V. Pavan
The anthranilic acid diamides represent the most recent class of nonpeptide CCK(1) receptor (CCK(1)-R) antagonists. Herein we describe the second phase of the anthranilic acid C-terminal optimization using nonproteinogenic amino acids containing a ph
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d53c4bddd1e8d47f015714250acdc23
http://hdl.handle.net/11573/390098
http://hdl.handle.net/11573/390098
Publikováno v:
ChemInform. 22
Publikováno v:
ChemInform. 23
The hydrosoluble triazene derivatives of phenylacetic, phenylbutyric and cinnamic acid have been synthesized and their logP and pKa values were simultaneously determined according to a multiparametric fitting of potentiometric data. The antitumor act
Publikováno v:
ChemInform. 27
A series of 2-methyl-3-amino-4(H)-quinazolinone and of 2-phenyl-3-amino-4(H)-quinazolinone derivatives were synthesized and examined for their CCK receptor affinities. These compounds displayed micromolar affinities for CCK-B rather than CCK-A recept
Publikováno v:
ChemInform. 31
We have described previously an innovative bond disconnection strategy of asperlicin, a naturally occurring CCK receptor antagonist, leading to anthranilic acid dimer and tryptophan synthons. We have also demonstrated that when the tryptophan residue